Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
FHTX | US
-0.50
-6.00%
Healthcare
Biotechnology
30/06/2024
04/10/2024
7.83
7.43
8.09
7.43
Foghorn Therapeutics Inc. a clinical-stage biopharmaceutical company engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify validate and potentially drug targets within the system. It develops FHD-286 a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609 a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor and a protein degrader as selective modulators of BRM; and ARID1B selective modulators for the treatment of ovarian endometrial colorectal bladder and gastric cancers. It has a research collaboration and license agreement with Merck Sharp & Dohme Corp. to discover and develop novel oncology therapeutics against a transcription factor target; and Loxo Oncology to create novel oncology medicines. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge Massachusetts.
View LessLow Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
71.9%1 month
113.6%3 months
109.0%6 months
97.0%-
-
10.71
-2.86
0.12
-1.21
7.78
-
-91.63M
433.22M
433.22M
-
-351.83
-
23.00
-470.38
6.34
2.63
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.82
Range1M
2.82
Range3M
5.48
Rel. volume
0.75
Price X volume
1.37M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Anavex Life Sciences Corp | AVXL | Biotechnology | 5.595 | 474.43M | -1.06% | n/a | 0.00% |
OABI | OABI | Biotechnology | 3.99 | 471.47M | -1.97% | n/a | 8.27% |
Valneva SE | VALN | Biotechnology | 5.8116 | 471.18M | 1.78% | n/a | 126.08% |
Ginkgo Bioworks Holdings Inc. | DNA | Biotechnology | 8.33 | 462.94M | 8.04% | n/a | 54.29% |
EyePoint Pharmaceuticals Inc | EYPT | Biotechnology | 8.63 | 461.86M | 5.12% | n/a | 10.20% |
Quanterix Corporation | QTRX | Biotechnology | 11.9 | 456.71M | -4.80% | n/a | 11.75% |
Mind Medicine (MindMed) Inc. Subordinate Voting Shares | MNMD | Biotechnology | 5.57 | 456.67M | 0.36% | n/a | 12.00% |
Alector Inc | ALEC | Biotechnology | 4.62 | 449.62M | 2.67% | n/a | 23.98% |
Xeris Pharmaceuticals Inc | XERS | Biotechnology | 2.98 | 444.02M | 2.41% | n/a | -1398.96% |
Absci Corporation Common Stock | ABSI | Biotechnology | 3.88 | 440.60M | 2.11% | n/a | 6.02% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -1.21 | 0.76 | Cheaper |
Ent. to Revenue | 7.78 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 10.71 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 109.04 | 74.67 | Riskier |
Debt to Equity | -2.86 | -1.82 | Cheaper |
Debt to Assets | 0.12 | 0.26 | Cheaper |
Market Cap | 433.22M | 3.73B | Emerging |